Lv1
30 积分 2025-04-11 加入
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii
21天前
已完结
Intrathecal or intraventricular antimicrobial therapy for post-neurosurgical Gram-negative bacillary meningitis or ventriculitis: a systematic review and meta-analysis
2个月前
已完结
Pharmacodynamic target attainment at infection site during treatment of post-neurosurgical ventriculitis caused by carbapenem-resistant klebsiella pneumoniae with ceftazidime–avibactam–based regimens: a case report
2个月前
已完结
Impact of prescribing vancomycin capsules vs liquid at discharge on readmissions for C. difficile infection
2个月前
已完结
Guillain-Barré syndrome
3个月前
已完结
The Effectiveness of Newer Beta-Lactams for the Treatment of Antimicrobial-Resistant Gram-Negative Meningitis
5个月前
已完结
Effectiveness of ceftazidime–avibactam versus ceftolozane–tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study
5个月前
已完结
Novel agents in development for the treatment of resistant Gram-negative infections
6个月前
已完结
皖公网安备34019202002308
